Result Summary for 106066
| Protocol ID: | 106066 |
| Clinical Study ID: | ROP106066 |
| Official Title: | Clinical Evaluation of ropinirole PR/XR Tablet for Adjunctive Therapy to L-dopa in subjects with advanced Parkinson’s disease |
| Phase: | phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | ropinirole |
| Trade/Product Name: | Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
